Sam Altman is reportedly entering in brain-computer interface domain through a new startup, Merge Labs. The company is ...

Microsoft (NASDAQ:MSFT)-backed OpenAI co-founder Sam Altman is gearing up to back Merge Labs, a new brain-computer interface startup that could go head-to-head with Elon Musk's Neuralink, the ...

Neuralink is a dominant force in the BCI space, but the arrival of a new, well-capitalised startup in Merge Labs may change the conversation.

Merge Labs will compete with Elon Musk’s Neuralink, which is developing computer interface chips designed to be implanted in ...

Sam Altman, the OpenAI co-founder valued at the center of artificial intelligence's rapid ascent, is preparing a challenge to ...

The Financial Times reports today that Sam Altman has OpenAI planning to invest in a new brain-computer interface (BCI) venture, Merge Labs.

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting ...

Merge Labs is a new Neuralink rival developing brain-computer interfaces. If you’ve enjoyed Elon Musk’s ongoing beef with ...

The brain chip company that has drawn interest from Sam Altman and his artificial intelligence business OpenAI is exploring ...

The new venture will go head-to-head with Elon Musk’s brain chip startup Neuralink. Altman is reportedly betting that AI can ...

OpenAI, led by Sam Altman, is reportedly planning to invest in a new venture called Merge Labs, which will compete with Elon ...

In a strategic move, OpenAI CEO Sam Altman is reportedly planning to invest in a brain implant startup, called Merge Labs, ...